Key Metrics
10.69
Heat Index-
Impact LevelMedium
-
Scope LevelNational
-
Last Update2025-09-09
Key Impacts
Positive Impacts (6)
Tourmaline Bio (TRML)
Novartis AG (NVS)
Nasdaq Biotechnology Index (NBI)
U.S. Small-/Mid-Cap Biotechnology ETF (e.g., XBI)
Swiss Market Index (SMI)
Investment-Grade Healthcare Corporate Bonds
Total impacts: 6 |
Positive: 6 |
Negative: 0
Event Overview
The acquisition highlights a strategic move in the biopharmaceutical industry, reflecting the consolidation and expansion of major players. It underscores the economic and competitive dynamics driving corporate growth through mergers and acquisitions.
Collect Records
诺华宣布以每股48美元收购Tourmaline
2025-09-09 13:19
9月9日，诺华宣布达成协议，将以每股48美元的现金价格收购生物制药公司Tourmaline的所有流通普通股。收购完成后，Tourmaline将成为诺华的间接全资子公司。
Total records: 1